| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 301 | 837 | 3.891 | 1.308 | 930 | 229 | 127 | 1.133 | 2.183 | 6.648 |
| Total Income - EUR | 301 | 837 | 3.891 | 1.308 | 930 | 731 | 127 | 1.133 | 2.183 | 6.847 |
| Total Expenses - EUR | 4.795 | 4.315 | 7.659 | 11.960 | 10.306 | 8.374 | 6.878 | 6.372 | 7.714 | 11.799 |
| Gross Profit/Loss - EUR | -4.494 | -3.478 | -3.769 | -10.652 | -9.377 | -7.643 | -6.751 | -5.239 | -5.531 | -4.952 |
| Net Profit/Loss - EUR | -4.503 | -3.504 | -3.870 | -10.665 | -9.386 | -7.645 | -6.752 | -5.250 | -5.553 | -5.157 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Parsmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 312 | 531 | 522 | 513 | 503 | 10.194 | 9.766 | 9.796 | 9.767 | 9.712 |
| Current Assets | 2.887 | 3.267 | 3.755 | 4.022 | 3.476 | 5.755 | 5.438 | 4.655 | 3.608 | -113 |
| Inventories | 2.311 | 2.763 | 3.477 | 3.724 | 3.272 | 3.210 | 2.488 | 2.496 | 2.488 | 516 |
| Receivables | 183 | 179 | 30 | 32 | 0 | 2.445 | 2.367 | 2.159 | 1.752 | 0 |
| Cash | 394 | 325 | 248 | 267 | 204 | 100 | 583 | 0 | -633 | -629 |
| Shareholders Funds | -29.083 | -32.290 | -35.614 | -45.626 | -54.128 | -60.748 | -66.152 | -71.608 | -76.943 | -81.671 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.282 | 36.088 | 39.891 | 50.160 | 58.107 | 76.697 | 81.357 | 86.059 | 90.318 | 91.270 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Parsmed S.r.l.